AtriCure Inc (NAS:ATRC)
$ 22.5 -1.265 (-5.32%) Market Cap: 1.09 Bil Enterprise Value: 1.11 Bil PE Ratio: 0 PB Ratio: 2.39 GF Score: 72/100

AtriCure Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 14, 2020 / 06:15PM GMT
Release Date Price: $41.8 (+2.80%)
Fang Chu;Michael H. Carrel
Morgan Stanley, Research Division - Research Associate;AtriCure, Inc. - CEO, President &

All right. Good afternoon, everyone, and thank you for joining us on day 1 of the Morgan Stanley Healthcare Conference. My name is Calvin Chu, and I'm part of the Morgan Stanley medtech equity research team. It's my pleasure to have with us today Mike Carrel, President and CEO of AtriCure.

Before we begin, here is our disclaimer for the event. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclosures, please see Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

With that, Mike, thanks so much for being here with us today.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot